[Immunomodulating therapy in insulin-dependent diabetes mellitus: problems and new prospects].
Galenok
V A
VA
Zhuk
E A
EA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy / Q000276:immunology; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D004198:Disease Susceptibility; D006801:Humans; D011446:Prospective Studies
D000276:Adjuvants, Immunologic